Offers stem cell researchers a method of opening the zona for insertion or withdrawal of genetic material. From Hamilton Thorne Biosciences Inc., Beverly, Massachusetts

Developing therapies for the treatment of bone defects and myocardial regeneration, utilizing somatic stem cells isolated from cord blood. Based in Cambridge, Massachusetts.

Offers isolation and concentration from a sample of fat for treatment of injuries to tendons, ligaments, and fractures in performance horses. Includes explanation, case studies, news, description of services for horse owners and veterinarians, with contac

Research and development of retrodifferentiation technology, used to create stem cells from mature adult cells. Includes technological and corporate overview, with FAQ and contacts in London, UK.

Developing therapy by the transplantation of the patient's own cell-line after isolation and processing in vitro, to replace, repair or enhance the function of damaged tissues. Clinical trials based in Bangkok, Thailand and Kiryat Weizmann, Israel.

Offers lines of normal human embryonic stem cells, and genetically abnormal variants to scientists and researchers. with sub-licensing to commercial and scientific institutions from London, UK.

Directory of companies involved in stem cell research and development.

Specialist contract research organaization, offering kits for selection and enrichment from embryonic, epithelial hematopoietic or neural origin, and cloning of either hybridomas or non-adherent stably transfected cells. International laboratories headqua

Developing somatic transplantation technology for diabetes, neuronal degeneration and therapy for brain damage including stroke, Parkinson's disease, Alzheimer's and Huntington's disease. Overview of company in Guildford, England.

Specializing initially in hematopoietic stem cells and developing expansion from umbilical cord blood using its proprietary bioreactor and 3-D technology platform. Includes investor data and overview of company in Haifa, Israel.

Formed in 2002 to develop new in vivo tissue engineering technology for damaged or missing teeth, including growth of patient-matched dental implants. Contacts and introduction to research at Guy’s Hospital, London, UK.

Biotech company in the field of cell therapies including skin and hair regeneration products. Currently in clinical phase 3 trials in the USA, Canada and UK, headquartered in Cambridge, England.

Discovers and develops therapeutic and diagnostic products, as well as projects for cancer, skin aging, atherosclerosis, osteoporosis and macular degeneration. Headquartered in Menlo Park, California. (Nasdaq: GERN)

Consultant to the global stem cell, tissue engineering and regenerative medicine industry.

A device for the clinical preparation of autologous peripheral blood progenitor cells. Describes the product with illustrations, and contacts in Winston-Salem, North Carolina.

Offers ISO 17025 compliant storage of stem cells derived from the umbilical cord blood or bone marrow, and associated testing in Harrow, England.

Inventors of ethical umbilical cord mesenchymal and epithelial progenitor cell lines targeted at regenerative medicine. Also offering primary skin cell culture systems, both normal and diseased, and customised research in Singapore.

Company conducts research using autologous human cells in a serum free medium to treat incurable diseases. The results propose possible new treatments for regeneration of diseased tissues. Based in Geneva, Switzerland.

Antibodies, markers, reagents and recent reviews of their applications, links to conferences. Online catalog and purchase available from Cambridge, England and Massachusetts.

Bimonthly publication, formerly the Journal of Hematotherapy and Stem Cell Research, covering all tissue types, their potential therapeutic applications, and contentious issues in conventional medicine. Includes sample articles, abstracts and search with